Assignee
HOON DAVE S B
US·4 granted patents·23 pending applications·57 citations·filing 2008–2013
Top patents by PatentIndex Score
27 records- 0192US9567640B2Utility of B-RAF DNA mutation in diagnosis and treatment of cancerHOON DAVE S B·Filed 2012·Granted Feb 14, 2017·13 cites·10 claims
- 0292US9556491B2Utility of B-RAF DNA mutation in diagnosis and treatment of cancerHOON DAVE S B·Filed 2008·Granted Jan 31, 2017·14 cites·18 claims
- 0388US9410206B2Long noncoding RNA (lncRNA) as a biomarker and therapeutic marker in cancerHOON DAVE S B·Filed 2012·Granted Aug 9, 2016·30 cites·13 claims
- 0467US8288099B2Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancerHOON DAVE S B·Filed 2009·Granted Oct 16, 2012·0 cites·9 claims
- 0566US2013345144A1Use of ID4 for Diagnosis and Treatment of CancerHOON DAVE S B·Filed 2009·Application pending·0 cites
- 0663US2011151465A1Use of methylated or unmethylated line-1 dna as a cancer markerHOON DAVE S B·Filed 2010·Application pending·0 cites
- 0763US2011159510A1Use of methylated or unmethylated line-1 dna as a cancer markerHOON DAVE S B·Filed 2010·Application pending·0 cites
- 0863US2011159502A1Use of methylated or unmethylated line-1 dna as a cancer markerHOON DAVE S B·Filed 2010·Application pending·0 cites
- 0963US2011159501A1Use of methylated or unmethylated line-1 dna as a cancer markerHOON DAVE S B·Filed 2010·Application pending·0 cites
- 1060US2012301477A1USE OF CCR9, CCL25/TECK, AND INTEGRIN alpha4 IN DIAGNOSIS AND TREATMENT OF MELANOMA METASTASIS IN THE SMALL INTESTINEHOON DAVE S B·Filed 2012·Application pending·0 cites
- 1157US2011097727A1Dna markers for management of cancerHOON DAVE S B·Filed 2010·Application pending·0 cites
- 1256US2012088683A1Detection of Cancer Cells in Body FluidsHOON DAVE S B·Filed 2011·Application pending·0 cites
- 1355US2010330567A1Dna markers for management of cancerHOON DAVE S B·Filed 2010·Application pending·0 cites
- 1455US2011171660A1Use of ccr9, ccl25/teck, and integrin alpha4 in diagnosis and treatment of melanoma metastasis in the small intestineHOON DAVE S B·Filed 2010·Application pending·0 cites
- 1554US2012148561A1Use of runx3 and mir-532-5p as cancer markers and therapeutic targetsHOON DAVE S B·Filed 2012·Application pending·0 cites
- 1654US2011206705A1B7-h3 as a biomarker for diagnosing the progression and early lymph node metastasis of cancerHOON DAVE S B·Filed 2010·Application pending·0 cites
- 1753US2011171240A1Use of ccr9, ccl25/teck, and integrin alpha4 in diagnosis and treatment of melanoma metastasis in the small intestineHOON DAVE S B·Filed 2010·Application pending·0 cites
- 1852US2011123602A1Molecular lymphatic mapping of sentinel lymph nodesHOON DAVE S B·Filed 2010·Application pending·0 cites
- 1951US2011158975A1Use of runx3 and mir-532-5p as cancer markers and therapeutic targetsHOON DAVE S B·Filed 2010·Application pending·0 cites
- 2051US2011159509A1Use of runx3 and mir-532-5p as cancer markers and therapeutic targetsHOON DAVE S B·Filed 2010·Application pending·0 cites
- 2150US2013323740A1Direct blood assay for detection of circulating microrna in cancer patientsHOON DAVE S B·Filed 2013·Application pending·0 cites
- 2246US2011212444A1Use of methylation status of mint loci and tumor related genes as a marker for melanoma and breast cancerHOON DAVE S B·Filed 2010·Application pending·0 cites
- 2344US2011091970A1Methylation of estrogen receptor alpha and uses thereofHOON DAVE S B·Filed 2010·Application pending·0 cites
- 2442US2011195499A1Utility of ret mutant in diagnosis and treatment of melanomaHOON DAVE S B·Filed 2010·Application pending·0 cites
- 2540US2011124004A1Utility of high molecular weight melanoma associated antigen in diagnosis and treatment of cancerHOON DAVE S B·Filed 2010·Application pending·0 cites
- 2640US2011124007A1Utility of high molecular weight melanoma associated antigen in diagnosis and treatment of cancerHOON DAVE S B·Filed 2010·Application pending·0 cites
- 2738US2011098341A1Use of id4 for diagnosis and treatment of cancerHOON DAVE S B·Filed 2010·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →